Ventyx 生物科學公司
US ˙ NasdaqGS ˙ US92332V1070
該符號不再有效

SecurityVTYX / Ventyx Biosciences, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership118,702 shares
Latest Disclosed Value $ 1,071,879
Barclays Plc reports 6,400.66% increase in ownership of VTYX / Ventyx Biosciences, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 118,702 shares of Ventyx Biosciences, Inc. (US:VTYX) valued at $1,071,879 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 1,826 shares of Ventyx Biosciences, Inc.. This represents a change in shares of 6,400.66% during the quarter. The current value of the position is $1,661,828 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F VENTYX BIOSCIENCES COM 92332V107 118,702 116,876 6,400.66 1,072 21,320.00 0.0003
2026-03-31 2025-09-30 13F/A-3 VENTYX BIOSCIENCES COM 92332V107 1,826 -103,571 -98.27 6 -97.78 0.0000
2026-03-19 2025-09-30 13F/A-2 VENTYX BIOSCIENCES COM 92332V107 80,295 -25,102 175 0.0000
2025-11-12 2025-09-30 13F VENTYX BIOSCIENCES COM 92332V107 1,826 -103,571 6 0.0000
2026-02-27 2025-06-30 13F/A-2 VENTYX BIOSCIENCES COM 92332V107 105,397 44,034 71.76 226 221.43 0.0001
2025-08-14 2025-06-30 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 105,397 44,034 0 0.0001
2025-08-13 2025-06-30 13F VENTYX BIOSCIENCES COM 92332V107 105,397 44,034 0 0.0000
2026-03-17 2025-03-31 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 61,363 -30,306 -33.06 71 -65.00 0.0000
2025-05-15 2025-03-31 13F VENTYX BIOSCIENCES COM 92332V107 61,363 -30,306 0 0.0000
2026-03-19 2024-12-31 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 91,669 11,374 14.17 201 14.29 0.0001
2025-02-13 2024-12-31 13F VENTYX BIOSCIENCES COM 92332V107 91,669 11,374 0 0.0001
2026-03-31 2024-09-30 13F/A-2 VENTYX BIOSCIENCES COM 92332V107 80,295 58,776 273.14 175 257.14 0.0000
2024-11-19 2024-09-30 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 80,295 58,776 0 0.0000
2024-11-15 2024-09-30 13F VENTYX BIOSCIENCES COM 92332V107 80,295 58,776 0 0.0000
2026-03-23 2024-06-30 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 21,519 -11,487 -34.80 50 -72.93 0.0000
2024-08-14 2024-06-30 13F VENTYX BIOSCIENCES COM 92332V107 21,519 -11,487 0 0.0000
2026-03-24 2024-03-31 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 33,006 -40,258 -54.95 182 0.56 0.0001
2024-05-15 2024-03-31 13F VENTYX BIOSCIENCES COM 92332V107 33,006 -40,258 0 0.0001
2026-03-25 2023-12-31 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 73,264 -154,956 -67.90 181 -97.73 0.0001
2024-02-15 2023-12-31 13F VENTYX BIOSCIENCES COM 92332V107 73,264 -154,956 0 0.0001
2026-03-26 2023-09-30 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 228,220 204,762 872.89 7,926 930.69 0.0049
2023-11-07 2023-09-30 13F VENTYX BIOSCIENCES COM 92332V107 228,220 204,762 8 0.0049
2026-03-30 2023-06-30 13F/A-2 VENTYX BIOSCIENCES COM 92332V107 23,458 5,954 34.02 769 31.23 0.0005
2023-09-20 2023-06-30 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 23,458 5,954 1 0.0005
2023-08-03 2023-06-30 13F VENTYX BIOSCIENCES COM 92332V107 23,458 5,954 1 0.0005
2026-03-30 2023-03-31 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 17,504 6,669 61.55 586 65.07 0.0003
2023-05-04 2023-03-31 13F VENTYX BIOSCIENCES COM 92332V107 17,504 6,669 1 0.0003
2026-03-30 2022-12-31 13F/A-1 VENTYX BIOSCIENCES COM 92332V107 10,835 7,787 255.48 355 234.91 0.0002
2023-02-13 2022-12-31 13F VENTYX BIOSCIENCES COM 92332V107 10,835 7,787 0 0.0002
2022-11-03 2022-09-30 13F VENTYX BIOSCIENCES COM 92332V107 3,048 -275,335 -98.91 106 -96.89 0.0001
2022-08-12 2022-06-30 13F VENTYX BIOSCIENCES COM 92332V107 278,383 -10,657 -3.69 3,406 -13.18 0.0021
2022-05-16 2022-03-31 13F VENTYX BIOSCIENCES COM 92332V107 289,040 289,040 3,923 0.0031
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.